MediciNova, Inc.
MNOV
$1.79
$0.042.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 145.13% | 23.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 145.13% | 23.27% | |||
| Cost of Revenue | -17.28% | 15.71% | |||
| Gross Profit | 1,780.47% | 252.08% | |||
| SG&A Expenses | 15.07% | 2.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.77% | -6.82% | |||
| Operating Income | 10.39% | 8.30% | |||
| Income Before Tax | 10.52% | 7.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.52% | 7.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.52% | 7.71% | |||
| EBIT | 10.39% | 8.30% | |||
| EBITDA | 10.43% | 8.30% | |||
| EPS Basic | 10.48% | 8.06% | |||
| Normalized Basic EPS | 10.37% | 7.87% | |||
| EPS Diluted | 10.48% | 8.06% | |||
| Normalized Diluted EPS | 10.37% | 7.87% | |||
| Average Basic Shares Outstanding | 0.00% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||